Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1729319
Max Phase: Preclinical
Molecular Formula: C14H13BrN2O3
Molecular Weight: 337.17
Molecule Type: Small molecule
Associated Items:
ID: ALA1729319
Max Phase: Preclinical
Molecular Formula: C14H13BrN2O3
Molecular Weight: 337.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(NC(=O)c2cc(C3CC3)on2)ccc1Br
Standard InChI: InChI=1S/C14H13BrN2O3/c1-19-13-6-9(4-5-10(13)15)16-14(18)11-7-12(20-17-11)8-2-3-8/h4-8H,2-3H2,1H3,(H,16,18)
Standard InChI Key: FWHKITHKTPMYIP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 337.17 | Molecular Weight (Monoisotopic): 336.0110 | AlogP: 3.58 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.36 | CX Basic pKa: | CX LogP: 3.05 | CX LogD: 3.05 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.93 | Np Likeness Score: -1.76 |
1. PubChem BioAssay data set, |
Source(1):